Ingalls & Snyder LLC Codexis, Inc. Transaction History

Ingalls & Snyder LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 27, 2021	SELL	$11.7 - $23.41 $229,062 - $458,320	-19,578 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$9.8 - $12.77 $678,150 - $883,671	-69,199 Reduced 77.95%	19,578 $223,000
Q1 2020 Apr 22, 2020	SELL	$8.78 - $18.6 $102,330 - $216,783	-11,655 Reduced 11.6%	88,777 $991,000
Q4 2019 Jan 15, 2020	SELL	$13.12 - $17.06 $53,792 - $69,946	-4,100 Reduced 3.92%	100,432 $1.61 Million
Q3 2019 Oct 16, 2019	SELL	$12.75 - $19.01 $591,944 - $882,577	-46,427 Reduced 30.75%	104,532 $1.43 Million
Q2 2019 Jul 11, 2019	SELL	$17.0 - $21.88 $34,000 - $43,760	-2,000 Reduced 1.31%	150,959 $2.78 Million
Q1 2019 Apr 11, 2019	SELL	$15.53 - $22.15 $17,083 - $24,365	-1,100 Reduced 0.71%	152,959 $3.14 Million
Q4 2018 Jan 24, 2019	SELL	$14.06 - $22.57 $139,194 - $223,443	-9,900 Reduced 6.04%	154,059 $2.57 Million
Q3 2018 Oct 24, 2018	BUY	$13.35 - $19.1 $2.19 Million - $3.13 Million	163,959 New	163,959 $2.81 Million

141

60.8M

68.5K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $164M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.